ArticleScientific reports2026
Predictive modelling of tetracycline removal by I-Bi/Bi
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A visible-light responsive heterostructure photocatalyst (I-Bi/Bi₂WO₆/MWCNTs) was successfully synthesized using an ethylene glycol-assisted hydrothermal method for the photodegradation of the tetracycline (TC) antibiotic. To analyze and streamline the process performance, a hybrid machine learning model that incorporated artificial neural networks (ANN) with particle swarm optimization (PSO) and response surface methodology (RSM) was applied to forecast and optimize key operating parameters, such as solution pH, initial TC concentration, contact time, and photocatalyst dosage. The 4-8-1 topology of ANN-PSO was found to be the optimal network, and the prediction model of TC removal was demonstrated as a matrix of explicit equations. The R² of randomized training (0.98), testing (0.99), and validation (0.96) at the optimized topology confirms the efficiency of the developed ANN-PSO model. The ANN-PSO model showed a better predictive performance in comparison with the RSM model (R² = 0.960, RMSE = 5.379), with the correlation coefficient (0.981) being higher and the RMSE (4.712) lower. A 96.8% TC removal was achieved at solution pH 8, initial TC concentration of 20 mg/L, contact time of 160 min, and photocatalyst dosage of 25 mg.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.